Vanguard Group’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $17.3M | Sell |
|
|||||
|
2021
Q1 | $9.95M | Buy |
|
|||||
|
2020
Q4 | $8.55M | Buy |
|
|||||
|
2020
Q3 | $8.43M | Sell |
|
|||||
|
2020
Q2 | $8.88M | Buy |
|
|||||
|
2020
Q1 | $7.69M | Buy |
|
|||||
|
2019
Q4 | $16.2M | Buy |
|
|||||
|
2019
Q3 | $12.9M | Buy |
|
|||||
|
2019
Q2 | $14.2M | Buy |
|
|||||
|
2019
Q1 | $15.4M | Buy |
|
|||||
|
2018
Q4 | $15.6M | Buy |
|
|||||
|
2018
Q3 | $19.7M | Buy |
|
|||||
|
2018
Q2 | $14.2M | Buy |
|
|||||
|
2018
Q1 | $9.69M | Buy |
|
|||||
|
2017
Q4 | $9.61M | Buy |
|
|||||
|
2017
Q3 | $6.67M | Buy |
|
|||||
|
2017
Q2 | $6.41M | Buy |
|
|||||
|
2017
Q1 | $3.33M | Buy |
|
|||||
|
2016
Q4 | $1.82M | Sell |
|
|||||
|
2016
Q3 | $2.16M | Buy |
|
|||||
|
2016
Q2 | $1.53M | Buy |
|
|||||
|
2016
Q1 | $1.47M | Buy |
|
|||||
|
2015
Q4 | $1.42M | Buy |
|
|||||
|
2015
Q3 | $1.97M | Buy |
|
|||||
|
2015
Q2 | $2.53M | Sell |
|
|||||
|
2015
Q1 | $2.66M | Buy |
|
|||||
|
2014
Q4 | $2.5M | Buy |
|
|||||
|
2014
Q3 | $2.82M | Buy |
|
|||||
|
2014
Q2 | $4.32M | Buy |
|
|||||
|
2014
Q1 | $2.8M | Buy |
|